Leppert D - Search Results

1

Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study.

Benkert P, Meier S, Schaedelin S, Manouchehrinia A, Yaldizli Ö, Maceski A, Oechtering J, Achtnichts L, Conen D, Derfuss T, Lalive PH, Mueller C, Müller S, Naegelin Y, Oksenberg JR, Pot C, Salmen A, Willemse E, Kockum I, Blennow K, Zetterberg H, Gobbi C, Kappos L, Wiendl H, Berger K, Sormani MP, Granziera C, Piehl F, Leppert D, Kuhle J; NfL Reference Database in the Swiss Multiple Sclerosis Cohort Study Group. Benkert P, et al. Among authors: leppert d. Lancet Neurol. 2022 Mar;21(3):246-257. doi: 10.1016/S1474-4422(22)00009-6. Lancet Neurol. 2022. PMID: 35182510

2

Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis.

Leppert D, Waubant E, Bürk MR, Oksenberg JR, Hauser SL. Leppert D, et al. Ann Neurol. 1996 Dec;40(6):846-52. doi: 10.1002/ana.410400606. Ann Neurol. 1996. PMID: 9007089

3

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.

Leppert D, Ford J, Stabler G, Grygar C, Lienert C, Huber S, Miller KM, Hauser SL, Kappos L. Leppert D, et al. Brain. 1998 Dec;121 ( Pt 12):2327-34. doi: 10.1093/brain/121.12.2327. Brain. 1998. PMID: 9874483

4

Medial medullary syndrome due to vertebral artery dissection.

Leppert D, Radue EW. Leppert D, et al. J Neurol Neurosurg Psychiatry. 2001 Jan;70(1):130-1. doi: 10.1136/jnnp.70.1.130. J Neurol Neurosurg Psychiatry. 2001. PMID: 11118265 Free PMC article. No abstract available.

5

Interleukin 15 stimulates production of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by human peripheral blood mononuclear cells.

Constantinescu CS, Grygar C, Kappos L, Leppert D. Constantinescu CS, et al. Among authors: leppert d. Cytokine. 2001 Feb 21;13(4):244-7. doi: 10.1006/cyto.2000.0818. Cytokine. 2001. PMID: 11237433

6

The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis.

Lindberg RL, De Groot CJ, Montagne L, Freitag P, van der Valk P, Kappos L, Leppert D. Lindberg RL, et al. Among authors: leppert d. Brain. 2001 Sep;124(Pt 9):1743-53. doi: 10.1093/brain/124.9.1743. Brain. 2001. PMID: 11522577

7

Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis.

Leppert D, Lindberg RL, Kappos L, Leib SL. Leppert D, et al. Brain Res Brain Res Rev. 2001 Oct;36(2-3):249-57. doi: 10.1016/s0165-0173(01)00101-1. Brain Res Brain Res Rev. 2001. PMID: 11690622 Review.

8

IFNbeta lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS.

Waubant E, Goodkin D, Bostrom A, Bacchetti P, Hietpas J, Lindberg R, Leppert D. Waubant E, et al. Among authors: leppert d. Neurology. 2003 Jan 14;60(1):52-7. doi: 10.1212/wnl.60.1.52. Neurology. 2003. PMID: 12525717 Clinical Trial.

9

Respiratory failure due to bilateral diaphragm palsy as an early manifestation of ALS.

Czapliński A, Strobel W, Gobbi C, Steck AJ, Fuhr P, Leppert D. Czapliński A, et al. Among authors: leppert d. Med Sci Monit. 2003 May;9(5):CS34-6. Med Sci Monit. 2003. PMID: 12761460

10

Neutralizing antibodies against IFN-beta in multiple sclerosis: antagonization of IFN-beta mediated suppression of MMPs.

Gilli F, Bertolotto A, Sala A, Hoffmann F, Capobianco M, Malucchi S, Glass T, Kappos L, Lindberg RL, Leppert D. Gilli F, et al. Among authors: leppert d. Brain. 2004 Feb;127(Pt 2):259-68. doi: 10.1093/brain/awh028. Epub 2003 Nov 7. Brain. 2004. PMID: 14607790

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

175 results

Search Page